DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
DRNA
Delisted
DRNA was delisted on the 27th of December, 2021.
45 hedge funds and large institutions have $39.5M invested in Dicerna Pharmaceuticals, Inc. in 2017 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 11 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
45
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.3M | |
| 2 | +$1.1M | |
| 3 | +$435K | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$340K |
| 5 |
6CM
683 Capital Management
New York
|
+$274K |
Top Sellers
| 1 | -$973K | |
| 2 | -$287K | |
| 3 | -$159K | |
| 4 |
Millennium Management
New York
|
-$113K |
| 5 |
BCM
Bourgeon Capital Management
Darien,
Connecticut
|
-$103K |